You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The MiQLab system can look for 27 different targets, allowing the detection of SARS-CoV-2 as well as the determination of specific variants.
The mutations in these underappreciated noncanonical genes were overrepresented in the E. coli genomes, indicating they were clinically relevant.
Despite the Q4 revenue increase, sales for FY2020 dropped 13 percent year over year to $5.2 million.
In PLOS this week: potential neuropsychiatric drug targets identified, analysis of foodborne pathogen genome, and more.
In PLOS this week: genomic and transcriptomic analysis of conjunctival melanoma, phylogenetic analysis of Clostridioides difficile, and more.
In PNAS this week: effect of mutagenic compounds on transcription in yeast, role for GATA6 in regulating sinus node development, and more.
The firm beat the consensus Wall Street estimate on the top line but fell short of the estimate on the bottom line.
Working with Amazon and Illumina software tools, startup ICBiome has built a platform to help hospitals spot clusters of pathogens early.
The company first submitted for 510(k) clearance last year and has received two additional information requests from the agency.
Several Treponema sublineages cropped up after a large antibiotic campaign, though sequence data suggests resistance may have arisen only once.
SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.
The New York Times reports that a new viral variant of concern has been identified in New York City.
In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.
CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.
